Edgewise Therapeutics, Inc., , a leading muscle disease biopharmaceutical company, today announced that Kevin Koch, Ph.D., President and Chief Executive Officer, will present at the 44th Annual J.P.

OPKO Health, Inc. OPK is well-poised for growth in the coming quarters, supported by the potential of RAYALDEE. The optimism ...

Next-Gen Oncology Drugs Set New Standards in Cancer TreatmentThe Global Cancer/Oncology Drugs Market is valued at USD 183.4 ...

Additionally, the state authorities have proposed the introduction of a mock Centralised Admission Process (CAP) round from ...

Esco Aster, a vertically integrated cell and derivatives CRDMO based at JTC LaunchPad Singapore, announced CMC manufacturing support for Shine-On Biomedical's HLA-G targeted exosome program.  Shine-On ...

JADE101 Phase 1 healthy volunteer trial ongoing; biomarker-rich interim data expected in the first half of 2026 Phase 2 clinical trial of JADE101 ...

ORR for BI-1808 combined with pembrolizumab represents a meaningful improvement over pembrolizumab monotherapy in recurrent ovarian cancer (8% ORR in KEYNOTE-100)The combination demonstrated a ...

ORR for BI-1808 combined with pembrolizumab represents a meaningful improvement over pembrolizumab monotherapy in recurrent ovarian cancer (8% ORR in KEYNOTE-100)The combination demonstrated a favorab ...

ArriVent BioPharma's furmonertinib demonstrates robust efficacy, CNS penetration, and tolerability in early trials. Read why ...

The State Common Entrance Test Cell, Maharashtra is expected to begin the registration process for the Maharashtra Common ...

The Mashpee Senior Center uses robocalls and text alerts to notify members of closures (for those who have provided a cell number). Robo calls may appear as spam; the number is 617-855-0125. When ...

Iovance Biotherapeutics Inc. (NASDAQ:IOVA) is one of the best biotech penny stocks to buy according to analysts.